Hong Hong Huang

Singapore General Hospital

Papers

4

Total Citations

56

H-Index

3

About

Dr. Hong Hong Huang is a urologic surgeon and researcher whose work centers on improving the diagnosis and treatment of prostate and bladder cancers through minimally invasive techniques and precision medicine. A key contribution is his pioneering evaluation of multiparametric MRI-ultrasonography fusion prostate biopsy using a stereotactic robotic-assisted transperineal platform. In a highly cited 2020 study (23 citations), he compared systematic versus targeted biopsy, advancing the field’s understanding of how to optimize cancer detection while reducing unnecessary sampling. Dr. Huang has also been instrumental in demonstrating the perioperative and oncological benefits of robotic cystectomy over open surgery for bladder cancer, particularly within Enhanced Recovery After Surgery programs (16 citations). His research further explores the prognostic and diagnostic value of the neutrophil-to-lymphocyte ratio (NLR) in prostate cancer, with studies showing its utility as a predictive biomarker in both post-prostatectomy and pre-biopsy settings. By integrating advanced robotics with evidence-based biomarkers, Dr. Huang’s work directly enhances surgical precision, recovery outcomes, and early cancer detection—impacting clinical practice in Singapore and beyond.

Research Focus

Key Achievements

3
H-Index
4
Papers
56
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Multiparametric MRI‐ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic‐assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy
23 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Singapore General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago